Filing Details

Accession Number:
0001493152-20-006352
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-14 15:00:38
Reporting Period:
2020-01-07
Accepted Time:
2020-04-14 15:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1086082 Cannapowder Inc. CAPD Pharmaceutical Preparations (2834) 870626333
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1774451 Marco Shai Cohen Ben Guriun St #1, B.s.r Tower 2
Bnei Break L3 5120149
Ceo And Chairman Of The Board Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-07 400,000 $0.01 400,000 No 4 M Direct
Common Stock Disposition 2020-01-07 396,000 $1.00 396,000 No 4 F Direct
Common Stock Acquisiton 2020-01-08 246,875 $0.61 10,904,837 No 4 P Indirect By MNSCO, LLC
Common Stock Acquisiton 2020-01-08 41,650 $1.80 10,946,487 No 4 P Indirect By MNSCO, LLC
Common Stock Acquisiton 2020-01-08 28,000 $0.85 10,974,487 No 4 P Indirect By MNSCO, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 P Indirect By MNSCO, LLC
No 4 P Indirect By MNSCO, LLC
No 4 P Indirect By MNSCO, LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Class E Common Stock Warrants (right to buy Disposition 2020-01-07 100,000 $0.00 100,000 $0.01
Common Stock Class E Common Stock Warrants (right to buy) Disposition 2020-01-07 50,000 $0.00 50,000 $0.01
Common Stock Class I Common Stock Warrants (right to buy) Disposition 2020-01-07 250,000 $0.00 250,000 $0.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-11-01 2022-11-01 No 4 M Direct
0 2019-01-31 2022-01-31 No 4 M Direct
0 2019-05-01 2021-05-01 No 4 M Direct
Footnotes
  1. On January 7, 2020, Mr. Cohen exercised, via a cashless exercise, Series E warrants to acquire 150,000 shares of common stock of the issuer and Series I warrants to acquire 250,000 shares of common stock of the issuer, at the exercise price of $0.01 per share.
  2. In connection with the cashless exercise of Series E warrants and Series I warrants by Mr. Cohen, the issuer withheld 4,000 shares of its common stock to satisfy the exercise price, and issued to Mr. Cohen the remaining 396,000 shares. The volume weighted average price of the common stock was $1.00.
  3. The reported shares are held directly by MNSCO, LLC ("MNSCO"), a limited liability company, 50.1% of which is beneficially owned by Matthew Bronfman (through BA LLC, an entity wholly owned by Mr. Bronfman), and 49.9% of which is beneficially owned by Shai Cohen. Each of MNSCO and Mr. Cohen is the reporting person herein. Mr. Cohen is the sole manager of MNSCO, has voting and dispositive power of shares held by MNSCO and may be deemed to beneficially own the shares held by MNSCO. Mr. Cohen disclaims beneficial ownership of the shares owned by MNSCO except to the extent of his 49.9% pecuniary interest therein.